The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The Biden administration had proposed late last year coverage of the popular medicines for obesity.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

But so far, though, the jury is still out on whether anti-obesity drugs and specifically the GLP-1 therapies positively impact overall healthcare costs. “Currently, there is scant GLP-1 weight loss ...